This clinical trial is focused on studying the effects of a medication called Trixeo Aerosphere on patients with Chronic Obstructive Pulmonary Disease (COPD). COPD is a long-term lung disease that makes it hard to breathe. The medication being tested is a combination of three active substances: budesonide, glycopyrronium bromide, and formoterol fumarate dihydrate. These substances are delivered through a pressurized inhaler, which helps patients breathe in the medication directly into their lungs.
The purpose of the study is to see how this medication affects the way patients breathe over a period of one month. Participants will use the inhaler as part of their daily routine. The study will observe changes in their breathing patterns, including how complex and variable their breathing is. This will help researchers understand if the medication can improve the breathing of people with stable COPD.
Throughout the study, participants will have their breathing measured at different times to see how it changes with the use of the medication. The study will also look at other aspects of lung function and symptoms, such as how often and how deeply patients breathe, and how they feel in terms of breathlessness. This information will help determine the effectiveness of the medication in managing COPD symptoms.
France 
